Electrolyte Abnormalities

Total Page:16

File Type:pdf, Size:1020Kb

Electrolyte Abnormalities Critical Care Credentials Required Electrolyte Abnormalities Interventions Medications • Maintain continuous cardiac monitoring • Potassium • Obtain lab values, ensure treatment decisions are based on • Calcium recent values • Magnesium • Hypertonic saline Hypokalemia • Monitor for cardiac rhythm changes, treat per appropriate guideline • Assess for low magnesium levels and treat accordingly, as potassium levels cannot be restored if magnesium levels are also low. • The following orders should be verified by transferring provider: ◦ Potassium Chloride - concentrations no greater than 20mEq/50ml D5W (or NS) for central lines and 10mEq/100ml D5W (or NS) for peripheral lines ➢ Central Lines: Serum K+ Dose Total Dose < 2.5 20mEq KCL q1hr x 5 100mEq 2.6 – 3.0 20mEq KCL q1hr x 4 80mEq 3.1 – 3.5 20mEq KCL q1hr x 3 60mEq ➢ Peripheral Lines: Serum K+ Dose Total Dose < 2.5 10mEq KCL q1hr x 10 100mEq 2.6- 3.0 10mEq KCL q1hr x 8 80mEq 3.1 – 3.5 10mEq KCL q1hr x 6 60mEq ➢ If patient’s creatinine is > 1.4, discuss with transferring provider or contact MRCC before administering potassium chloride. Hyperkalemia • Confirm any potassium level > 5.5 prior to treatment unless patient is hemodynamically unstable. • If iStat is available, recheck serum potassium every 30 minutes after treatment. • Monitor for cardiac rhythm changes, treat per appropriate guideline • The following orders should be verified by transferring provider: ◦ Moderate (6.0-7.0) without EKG changes: Critical Care Credentials Required Credentials Care Critical ➢ Sodium bicarbonate: 1 mEq/kg IV (max 100 mEq) Required Credentials Care Critical ➢ Insulin: 10 U IV (Peds: 0.1 U/kg, max 10 U) ➢ Dextrose: 25 g IV (Peds: 0.5 - 1 g/kg, max 25 g) ◦ Severe (>7.0) or Moderate (6.0-7.0) with EKG changes - same as above plus: ➢ Calcium gluconate: 1 g IV over 10 minutes (Peds: 100 mg/kg, max 1,000 mg) Calcium chloride may be given if diluted. ➢ Albuterol: 10 mg nebulized over 15 minutes (Peds: 2.5 mg if < 25 kg; 5.0 mg if > 25 kg) ◦ Severe (>7.0) with EKG changes & instability or cardiac arrest - same as above plus: ➢ Immediately give calcium chloride Pearls • Electrolyte imbalances can cause life-threatening arrhythmias • Never administer potassium as IV push! It can cause life-threatening arrhythmias. • Hyperkalemia in the setting of acute renal failure often requires emergent dialysis 211 Critical Care Credentials Required Critical Care Credentials Required Electrolyte Abnormalities Interventions Medications • Maintain continuous cardiac monitoring • Potassium • Obtain lab values, ensure treatment decisions are based on • Calcium recent values • Magnesium • Hypertonic saline Hyponatremia • Rapidly raising the serum sodium levels can be dangerous. Treatment should be gradual (over days), or more aggressive only if significant symptoms are present. • Brain tissue can swell with severely low or acutely low sodium levels, with the risk of stroke-like symptoms, altered mental status, brain herniation, or seizures. • In most cases, the only treatment needed is to restrict the patient’s water intake. • Verify pediatric orders with transferring physician. • Confirm with the transferring provider if treatment is indicated and obtain orders for medications. The following adult treatments are commonly used: ◦ 3% Saline – 50-100 mL over 10 minutes. Central line preferred, may give through a reliable peripheral IV ◦ 3% Saline continuous infusion – Confirm infusion rate and pump settings with transferring provider Hypomagnesemia • If patient’s creatinine is > 1.4, discuss with transferring provider or contact MRCC before administering magnesium. • Verify pediatric orders with transferring physician. • The following adult orders should be verified by transferring provider: ◦ Magnesium Sulfate – dilute to 2g in 50mL of 5% dextrose (D5), sterile water, or normal saline Serum Mg2+ Dose Total Dose < 1.0 mEq/L 2g over 1 hour x 2 4g 1.0 – 1.5 mEq/L 2g over 1 hour x 1 2g Hypocalcemia • Verify with the provider that treatment is indicated. Total serum calcium levels (reported as part of a standard basic metabolic panel) should not be used as indications for replacement. The actual active ion is in the form of ionized calcium which is a separate lab test, and should be used as the basis for calcium replacement. Critical Care Credentials Required Credentials Care Critical Critical Care Credentials Required Credentials Care Critical • Patients receiving transfusions of multiple units of blood products may also need calcium replacement, as preservatives in the blood products may bind to free calcium ions. • Verify pediatric orders with transferring physician. • The following adult orders should be verified by transferring provider: ◦ Calcium Chloride – administer via central line only, or dilute and slow push via peripheral line ◦ Calcium Gluconate – central line preferred, may administer through a reliable peripheral line Ionized Ca2+ Dose < 1 mmol/L 2g over 1 hour 1 – 1.1 mmol/L 1g over 1 hour Pearls • Avoid calcium if digoxin toxicity is suspected. Magnesium Sulfate (2gm over 5 min) may be used instead. 212 Critical Care Credentials Required.
Recommended publications
  • Calcium Chloride CAS N°:10043-52-4
    OECD SIDS CALCIUM CHLORIDE FOREWORD INTRODUCTION Calcium chloride CAS N°:10043-52-4 UNEP PUBLICATIONS 1 OECD SIDS CALCIUM CHLORIDE SIDS Initial Assessment Report For SIAM 15 Boston, USA 22-25th October 2002 1. Chemical Name: Calcium chloride 2. CAS Number: 10043-52-4 3. Sponsor Country: Japan National SIDS Contact Point in Sponsor Country: Mr. Yasuhisa Kawamura Director Second Organization Div. Ministry of Foreign Affairs 2-2-1 Kasumigaseki, Chiyoda-ku Tokyo 100 4. Shared Partnership with: 5. Roles/Responsibilities of the Partners: • Name of industry sponsor Tokuyama Corporation /consortium Mr. Shigeru Moriyama, E-mail: [email protected] Mr. Norikazu Hattori, E-mail: [email protected] • Process used 6. Sponsorship History • How was the chemical or This substance is sponsored by Japan under ICCA Initiative and category brought into the is submitted for first discussion at SIAM 15. OECD HPV Chemicals Programme ? 7. Review Process Prior to The industry consortium collected new data and prepared the the SIAM: updated IUCLID, and draft versions of the SIAR and SIAP. Japanese government peer-reviewed the documents, audited selected studies. 8. Quality check process: 9. Date of Submission: 10. Date of last Update: 2 UNEP PUBLICATIONS OECD SIDS CALCIUM CHLORIDE 11. Comments: No testing (X) Testing ( ) The CaCl2-HPV Consortium members: (Japan) Asahi Glass Co., Ltd. Central Glass Co., Ltd. Sanuki Kasei Co., Ltd. Tokuyama Corporation [a global leader of the CaCl2-HPV Consortium] Tosoh Corporation (Europe) Brunner Mond (UK) Ltd. Solvay S.A. (North America) The Dow Chemical Company General Chemical Industrial Products Inc. Tetra Technologies, Inc.
    [Show full text]
  • US EPA Inert (Other) Pesticide Ingredients
    U.S. Environmental Protection Agency Office of Pesticide Programs List of Inert Pesticide Ingredients List 3 - Inerts of unknown toxicity - By Chemical Name UpdatedAugust 2004 Inert Ingredients Ordered Alphabetically by Chemical Name - List 3 Updated August 2004 CAS PREFIX NAME List No. 6798-76-1 Abietic acid, zinc salt 3 14351-66-7 Abietic acids, sodium salts 3 123-86-4 Acetic acid, butyl ester 3 108419-35-8 Acetic acid, C11-14 branched, alkyl ester 3 90438-79-2 Acetic acid, C6-8-branched alkyl esters 3 108419-32-5 Acetic acid, C7-9 branched, alkyl ester C8-rich 3 2016-56-0 Acetic acid, dodecylamine salt 3 110-19-0 Acetic acid, isobutyl ester 3 141-97-9 Acetoacetic acid, ethyl ester 3 93-08-3 2'- Acetonaphthone 3 67-64-1 Acetone 3 828-00-2 6- Acetoxy-2,4-dimethyl-m-dioxane 3 32388-55-9 Acetyl cedrene 3 1506-02-1 6- Acetyl-1,1,2,4,4,7-hexamethyl tetralin 3 21145-77-7 Acetyl-1,1,3,4,4,6-hexamethyltetralin 3 61788-48-5 Acetylated lanolin 3 74-86-2 Acetylene 3 141754-64-5 Acrylic acid, isopropanol telomer, ammonium salt 3 25136-75-8 Acrylic acid, polymer with acrylamide and diallyldimethylam 3 25084-90-6 Acrylic acid, t-butyl ester, polymer with ethylene 3 25036-25-3 Acrylonitrile-methyl methacrylate-vinylidene chloride copoly 3 1406-16-2 Activated ergosterol 3 124-04-9 Adipic acid 3 9010-89-3 Adipic acid, polymer with diethylene glycol 3 9002-18-0 Agar 3 61791-56-8 beta- Alanine, N-(2-carboxyethyl)-, N-tallow alkyl derivs., disodium3 14960-06-6 beta- Alanine, N-(2-carboxyethyl)-N-dodecyl-, monosodium salt 3 Alanine, N-coco alkyl derivs.
    [Show full text]
  • Effect of Calcium Source and Exposure-Time on Basic Caviar Spherification Using Sodium Alginate
    Available online at www.sciencedirect.com International Journal of Gastronomy and Food Science International Journal of Gastronomy and Food Science 1 (2012) 96–100 www.elsevier.com/locate/ijgfs Scientific Paper Effect of calcium source and exposure-time on basic caviar spherification using sodium alginate P. Lee, M.A. Rogersn School of Environmental and Biological Sciences, Department of Food Science, Rutgers University, The State University of New Jersey, New Brunswick, NJ 08901, USA Received 24 February 2013; accepted 12 June 2013 Available online 21 June 2013 Abstract Gelation speed is directly proportional to the concentration of calcium. Although the kinetics of gelation are altered by the source of calcium, the final alginate gel strength nor the resistance to calcium diffusion are altered. Calcium chloride reaches a gel strength plateau fastest (100 s), followed by calcium lactate (500 s) and calcium gluconoate (2000 s). Calcium chloride is the best option when the bitter taste can be masked and a fast throughput is required, while calcium gluconoate may have an advantage when the membrane thickness/hardness needs to be manipulated. & 2013 AZTI-Tecnalia. Production and hosting by Elsevier B.V. All rights reserved. Keywords: Spherification; Calcium chloride; Calcium lactate; Calcium gluconate; Sodium alginate Introduction typically contain a physical outer gel membrane with a liquid core. Spherification, an old technique in the world of modernist Alginates are an attractive ingredient because they are cuisine, was pioneered at El Bulli in 2003 and is a cornerstone derived from marine brown algae (Mabeau and Fleurence, in experimental kitchens across the world (Vega and Castells, 1993) making them non-toxic, biodegradable and naturally 2012).
    [Show full text]
  • Sodium Alginate Gel Beads
    Jelly Beads! Procedure: 1. Always wear safety goggles. 2. Rinse the beaker, graduated cylinder and petri dish. 3. Measure 20 mL of calcium chloride solution with the graduated cylinder. Add it to the beaker. 4. Add three or four drops of sodium alginate to the beaker. What happened? 5. Use the scoop to transfer one or two of the alginate gel beads from the beaker to the petri dish. Leave the rest of the beads in the beaker for later. 6. • Rinse the beads in the petri dish with water. • Touch the beads. • Lightly roll and squeeze them between your fingers. What do they feel like? What could you use them for? 7. After at least a minute has passed, use the scoop to transfer another bead or two from the beaker to the petri dish. 8. Rinse these beads, and then feel them. Do they feel any different from the beads that you pulled out earlier? Why? 9. When you are finished experimenting, dump the beads and water in the waste container. Clean up for the next person. How did the alginate drops turn into jelly beads? How could you use the beads? A Closer Look: In this experiment you created a gel out of sodium alginate. A gel is a soft substance that has the properties of both liquids and solids. In this experiment, long chains of repeating molecules in the alginate – called polymers – became tangled into a net or mesh. How did it work? When you added calcium chloride, the calcium ions in the solution cross- linked the polymers in the alginate, attaching them to each other at many points.
    [Show full text]
  • Research Article Quality of Cucumbers Commercially Fermented in Calcium Chloride Brine Without Sodium Salts
    Hindawi Journal of Food Quality Volume 2018, Article ID 8051435, 13 pages https://doi.org/10.1155/2018/8051435 Research Article Quality of Cucumbers Commercially Fermented in Calcium Chloride Brine without Sodium Salts Erin K. McMurtrie1 and Suzanne D. Johanningsmeier 2 1 Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University, 400 Dan Allen Drive, Raleigh, NC 27695-7642, USA 2USDA-ARS,SEAFoodScienceResearchUnit,322SchaubHall,Box7624,NorthCarolinaStateUniversity, Raleigh, NC 27695-7624, USA Correspondence should be addressed to Suzanne D. Johanningsmeier; [email protected] Received 1 October 2017; Revised 5 December 2017; Accepted 20 December 2017; Published 26 March 2018 Academic Editor: Susana Fiszman Copyright © 2018 Erin K. McMurtrie. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Dr. Suzanne D. Johanningsmeier’s contribution to this article is a work of the United States Government, for which copyright protection is not available in the United States. 17 U.S.C. §105. Commercial cucumber fermentation produces large volumes of salty wastewater. Tis study evaluated the quality of fermented cucumbers produced commercially using an alternative calcium chloride (CaCl2) brining process. Fermentation conducted in calcium brines (0.1 M CaCl2, 6 mM potassium sorbate, equilibrated) with a starter culture was compared to standard industrial fermentation. Production variables included commercial processor (� = 6), seasonal variation (June–September, 2 years), vessel size (10,000–40,000 L), cucumber size (2.7–5.1 cm diameter), and bulk storage time (55–280 days). Cucumber mesocarp frmness, color, bloater defects, pH, and organic acids were measured.
    [Show full text]
  • Calcium Chloride a Guide to Physical Properties Table of Contents
    Calcium Chloride A Guide to Physical Properties Table of Contents About This Guide . 1 Physical Properties of Calcium Chloride Physical Properties of Calcium Chloride and Hydrates . 2 Solubility . .2 Moisture Absorption . 6 Surface Tension . .7 Specific Heat . 8 Viscosity . 8 Summary . 9 About This Guide This guide presents information on the physical properties of calcium chloride products from Occidental Chemical Corporation (OxyChem). It is intended to complement other OxyChem literature on calcium chloride products. It is not intended to serve as a complete and comprehensive technical reference for the topics presented. It is the responsibility of the end user to determine the most appropriate way to apply this information to their specific situation. OxyChem publishes and regularly updates Material Safety Data Sheets (MSDS) for each calcium chloride product it produces. These documents provide information on health and handling precautions, safety guidelines and product status relative to various government regulations. Obtain Material Safety Data Sheets and other product and application information at www.oxycalciumchloride.com. 1 Physical Properties of Calcium Chloride The data in the physical properties tables in this section are These conditions are defined by the phase diagram laboratory results typical of the products, and should not be of the calcium chloride-water system shown in confused with, or regarded as, specifications . Figure 1. This figure can be used to determine which Literature data on the physical properties of calcium phases are expected under different temperature and chloride, its hydrates and solutions generally refer concentration conditions. to pure material. Pure calcium chloride, however, is Concentrated solutions of calcium chloride have a only available in smaller quantities from chemical marked tendency to supercool; i.e., the temperature of reagent supply houses.
    [Show full text]
  • Spherification How-To
    Spherification how-to Directions from http://www.molecularrecipes.com/spherification-class/basic- spherification/. Another good resource is Chef's Steps: http://www.chefsteps.com/ activities/direct-spherification From Wikipedia.org: "Spherification is the culinary process of shaping a liquid into spheres which visually and texturally resemble roe. The technique was originally discovered by Unilever in the 1950s (Potter 2010, p. 305) and brought to the modernist cuisine by the creative team at elBulli under the direction of executive chef Ferran Adrià. There are two main methods for creating such spheres, which differ based on the calcium content of the liquid product to be spherified. For flavored liquids (such as fruit juices) containing no calcium, the liquid is thoroughly mixed with a small quantity of powdered sodium alginate, then dripped into a bowl filled with a cold solution of calcium chloride, or other soluble calcium salt. Just as a teaspoonful of water dropped into a bowl of vegetable oil forms a little bubble of water in the oil, each drop of the alginated liquid tends to form into a small sphere in the calcium solution. Then, during a reaction time of a few seconds to a few minutes, the calcium solution causes the outer layer of each alginated liquid sphere to form a thin, flexible skin. The resulting "popping boba" or artificial "caviar" balls are removed from the calcium-containing liquid bath, rinsed in a bowl of ordinary water, removed from the water and saved for later use in food or beverages. Reverse spherification, for use with substances which contain calcium or have high acid/alcohol content, requires dripping the substance (containing calcium lactate or calcium lactate gluconate) into an alginate bath.
    [Show full text]
  • PELADOWTM Calcium Chloride Pellets the Premier Snow and Ice Melter
    PELADOWTM Calcium Chloride Pellets The Premier Snow and Ice Melter ™ CALCIUM CHLORIDE PELLETS PREMIER SNOW AND ICE MELTER Proven Performance. Calcium Chloride: The Active Proven Customer Satisfaction. Ingredient Behind Superior No other ice-melt product works on snow and ice Ice-Melt Performance better than PELADOW™ Calcium Chloride While most ice melters are composed of one or Pellets. Customer satisfaction, comparative more of the following active ingredients (or a performance tests and scientific research prove blend of them), there are clear and scientifically that it’s the premier choice for ice melt. With its documented performance differences among fast melting action and cold-temperature perfor- ice-melt materials. The five materials are: mance, PELADOW calcium chloride is easily • Calcium chloride (CaCl ). distinguished from other ice melters because it: 2 • Sodium chloride (NaCl). • Contains more than 90 percent calcium chloride, the most effective material for • Potassium chloride (KCl). melting ice and snow. • Magnesium chloride (contains • Melts ice 2 to 5 times faster than competing approximately 50 percent water). ice-melt materials. • Urea (primarily used as a fertilizer). • Absorbs moisture and generates heat to Your ice melter’s formulation significantly speed melting. impacts your ability to clear snow and ice quickly • Penetrates through ice 2 to 4 times faster under all winter conditions. Below you’ll find a than competing materials. quick comparison chart that shows the difference between the melting power of PELADOW™ • Performs in a wider range of winter Calcium Chloride Pellets and the other four temperatures, even extreme cold. chemicals used as ice melters. • Provides peace of mind by making steps, walks, driveways and parking lots safer.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9.259,430 B2 Rathmacher Et Al
    US00925943OB2 (12) United States Patent (10) Patent No.: US 9.259,430 B2 Rathmacher et al. (45) Date of Patent: *Feb. 16, 2016 (54) NUTRITIONAL INTERVENTION FOR (56) References Cited IMPROVING MUSCULAR FUNCTION AND STRENGTH U.S. PATENT DOCUMENTS 4,992.470 A 2f1991 Nissen (71) Applicant: Metabolic Technologies, Inc., Ames, IA 5,028,440 A 7, 1991 Nissen (US) 5,087.472 A 2f1992 Nissen 5,348,979 A 9, 1994 Nissen et al. 5,360,613 A 11/1994 Nissen (72) Inventors: John Rathmacher, Story City, IA (US); 6,031,000 A 2/2000 Nissen et al. John Fuller, Jr., Zearing, IA (US); 6,103,764 A 8, 2000 Nissen Shawn Baier, Polk City, IA (US); Steve 6,291525 B1 9, 2001 Nissen 8,815,280 B2 * 8/2014 Rathmacher et al. ......... 424/439 Nissen, Ames, IA (US); Naji Abumrad, 2004f0071825 A1 4/2004 Lockwood Nashville, IA (US) 2005/0215640 A1 9, 2005 Baxter et al. 2006, OOO3947 A1 1, 2006 Udell (73) Assignee: Metabolic Technologies, Inc., Ames, IA 2007/0142469 A1 6/2007 Thomas et al. (US) FOREIGN PATENT DOCUMENTS (*) Notice: Subject to any disclaimer, the term of this patent is extended or adjusted under 35 WO 2008024456 A2 2, 2008 U.S.C. 154(b) by 0 days. OTHER PUBLICATIONS This patent is Subject to a terminal dis McCarty et al. (“Toward a Core Nutraceutical Program for Cancer claimer. Management” in Integrative Cancer Therapies 5(2); 2006.* Krebs, H. A. & Lund, P. (1977) Aspects of the regulation of the metabolism of branched-chain amino acids. Advan.
    [Show full text]
  • Estonian Statistics on Medicines 2016 1/41
    Estonian Statistics on Medicines 2016 ATC code ATC group / Active substance (rout of admin.) Quantity sold Unit DDD Unit DDD/1000/ day A ALIMENTARY TRACT AND METABOLISM 167,8985 A01 STOMATOLOGICAL PREPARATIONS 0,0738 A01A STOMATOLOGICAL PREPARATIONS 0,0738 A01AB Antiinfectives and antiseptics for local oral treatment 0,0738 A01AB09 Miconazole (O) 7088 g 0,2 g 0,0738 A01AB12 Hexetidine (O) 1951200 ml A01AB81 Neomycin+ Benzocaine (dental) 30200 pieces A01AB82 Demeclocycline+ Triamcinolone (dental) 680 g A01AC Corticosteroids for local oral treatment A01AC81 Dexamethasone+ Thymol (dental) 3094 ml A01AD Other agents for local oral treatment A01AD80 Lidocaine+ Cetylpyridinium chloride (gingival) 227150 g A01AD81 Lidocaine+ Cetrimide (O) 30900 g A01AD82 Choline salicylate (O) 864720 pieces A01AD83 Lidocaine+ Chamomille extract (O) 370080 g A01AD90 Lidocaine+ Paraformaldehyde (dental) 405 g A02 DRUGS FOR ACID RELATED DISORDERS 47,1312 A02A ANTACIDS 1,0133 Combinations and complexes of aluminium, calcium and A02AD 1,0133 magnesium compounds A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 811120 pieces 10 pieces 0,1689 A02AD81 Aluminium hydroxide+ Magnesium hydroxide (O) 3101974 ml 50 ml 0,1292 A02AD83 Calcium carbonate+ Magnesium carbonate (O) 3434232 pieces 10 pieces 0,7152 DRUGS FOR PEPTIC ULCER AND GASTRO- A02B 46,1179 OESOPHAGEAL REFLUX DISEASE (GORD) A02BA H2-receptor antagonists 2,3855 A02BA02 Ranitidine (O) 340327,5 g 0,3 g 2,3624 A02BA02 Ranitidine (P) 3318,25 g 0,3 g 0,0230 A02BC Proton pump inhibitors 43,7324 A02BC01 Omeprazole
    [Show full text]
  • ABSTRACT LOVETT, MALLORYE DELORIS. Calcium Chloride And
    ABSTRACT LOVETT, MALLORYE DELORIS. Calcium Chloride and Vitamin D Fortified Beverages: Bioavailability in Wistar Rats. (Under the direction of J.C. Allen.) Calcium and vitamin D deficiency is now recognized as an epidemic in the United States. Calcium and vitamin D play a critical role in the prevention of metabolic diseases including osteoporosis, osteomalacia, and rickets. Epidemiological research indicates that average intake of these nutrients is well below the RDA. Dairy products continue to be the main source of calcium intake. The major source of vitamin D is from sensible sun exposure. Greater intake of calcium and vitamin D has been correlated to a reduction in fractures, prevention of osteoporosis, and increased bone mass. The objective of this study was to test effects of a water-soluble form of vitamin D and calcium chloride as fortifiers for an aqueous sports drink solution with a rat bioavailability assay. A water-soluble vitamin D fortifying ingredient was prepared as a spray-dried complex with bovine beta-lactoglobulin. Vitamin D content of the complex was assessed by HPLC. Flavored beverages were formulated with various ratios of calcium and vitamin D in a 4x4 factorial design. Female Wistar rats were housed under incandescent lighting and randomly divided into the treatment and control groups. After a 4-week depletion phase, rats were given specialized drink formulations and low calcium, vitamin D-deficient diet for an additional six weeks. Blood and femur bones were removed for further analysis. Serum vitamin D was measured by ELISA. Results demonstrate that fortified drink solutions could be accurately formulated to contain calcium chloride at 0, 1, 2 and 2.5 g Ca/L with palatability to rats.
    [Show full text]
  • Calcium Chloride
    Version 6.2 SAFETY DATA SHEET Revision Date 04/20/2021 Print Date 10/02/2021 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifiers Product name : Calcium chloride Product Number : C8106 Brand : Sigma-Aldrich Index-No. : 017-013-00-2 CAS-No. : 10035-04-8 1.2 Relevant identified uses of the substance or mixture and uses advised against Identified uses : Laboratory chemicals, Synthesis of substances 1.3 Details of the supplier of the safety data sheet Company : Sigma-Aldrich Inc. 3050 SPRUCE ST ST. LOUIS MO 63103 UNITED STATES Telephone : +1 314 771-5765 Fax : +1 800 325-5052 1.4 Emergency telephone Emergency Phone # : 800-424-9300 CHEMTREC (USA) +1-703- 527-3887 CHEMTREC (International) 24 Hours/day; 7 Days/week SECTION 2: Hazards identification 2.1 Classification of the substance or mixture GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) Eye irritation (Category 2A), H319 For the full text of the H-Statements mentioned in this Section, see Section 16. 2.2 GHS Label elements, including precautionary statements Pictogram Signal word Warning Hazard statement(s) H319 Causes serious eye irritation. Sigma-Aldrich - C8106 Page 1 of 9 The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada Precautionary statement(s) P264 Wash skin thoroughly after handling. P280 Wear eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/ attention.
    [Show full text]